Availability of robotic-assisted surgery at a hospital was independently associated with greater use of partial nephrectomy.
A study found that targeted therapeutic agents for treating metastatic RCC has not led to an improvement in survival rates.
Ultrasound surveillance for renal tumors should be performed on native and graft kidneys from 3 years after transplantation.
Patients are 28% more likely to have partial nephrectomy at hospitals offering robotic-assisted surgery.
In adjusted analyses, female transplant recipients had a significantly increased risk of urologic cancer and men did not.
Study also finds increase in overall cancer rate among African-American children and adolescents.
Other predictors include neurovascular disease, obesity, and surgical approach.
The 3-year survival rates for patients diagnosed during 2006-2007 were similar to those diagnosed during 2001-2005.
Studies show integrated program effective for depression in patients with cancer.
Study shows a 3.5 times increased risk of death from renal cancer in hemodialysis patients undergoing nephrectomy.
Researchers find a greater than 50% reduction in end-stage renal disease risk compared with radical nephrectomy.
As body mass index increases, so does the risk of kidney and bladder cancers in men and stomach, ovarian, and colon cancers in women.
Study reveals a 2-fold greater likelihood of primary kidney and bladder cancer compared with men in the general population.
Increased abdominal adiposity is associated with a greater likelihood of clear-cell renal cell carcinoma.
Renal function is preserved better compared with radical nephrectomy even when tumors are larger than the traditional 4 cm cutoff.
Renal tumors occur at a frequency 7.5 times greater in lithium-treated patients than in the general population, French study shows.
At last follow-up, 41 of 43 patients who underwent partial nephrectomy did not require dialysis.